Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Leorah, Freeman"'
Autor:
Lynn Daboul, Carly M. O'Donnell, Quy Cao, Moein Amin, Paulo Rodrigues, John Derbyshire, Christina Azevedo, Amit Bar-Or, Eduardo Caverzasi, Peter Calabresi, Bruce A. C. Cree, Leorah Freeman, Roland G. Henry, Erin E. Longbrake, Kunio Nakamura, Jiwon Oh, Nico Papinutto, Daniel Pelletier, Rohini D. Samudralwar, Suradech Suthiphosuwan, Matthew K. Schindler, Elias S. Sotirchos, Nancy L. Sicotte, Andrew J. Solomon, Russell T. Shinohara, Daniel S. Reich, Daniel Ontaneda, Pascal Sati
Publikováno v:
American Journal of Roentgenology. 220:115-125
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b81ec55e6adc8359b65839eb4b1617e1
https://doi.org/10.2214/ajr.22.27731
https://doi.org/10.2214/ajr.22.27731
Autor:
Jeffrey English, Carlo Tornatore, Emily Riser, Gabriel Pardo, Leorah Freeman, Jacob Sloane, Elizabeth Piette, Christina Caon, Terrie Livingston
Publikováno v:
Thursday, April 27.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ea1b7ee89e1df312f3c49922cf51290
https://doi.org/10.1212/wnl.0000000000203517
https://doi.org/10.1212/wnl.0000000000203517
Autor:
Douglas L. Arnold, Leorah Freeman, Hans-Peter Hartung, Xavier Montalbán, Jeffrey A. Cohen, Amit Bar-Or, Lawrence Steinman, John DeLuca, Chun-Yen Cheng, Jon V. Riolo, Diego Silva, Chahin Pachai, Bruce A. C. Cree
Publikováno v:
Monday, April 24.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::704349e77910c046f19bd9850fe850be
https://doi.org/10.1212/wnl.0000000000202335
https://doi.org/10.1212/wnl.0000000000202335
Autor:
Helen-Margaret Onuorah, Odelin Charron, Ethan Meltzer, Amanda Montague, Alexis Crispino, Avery Largent, Ashlea Lucas, Leorah Freeman
Publikováno v:
Neurology. 98:e880-e892
Background and ObjectivesBlack and Hispanic people with multiple sclerosis (MS) (pMS) have been found to have different disease courses or worse outcomes associated with MS compared to White pMS. They are also more likely to be negatively affected by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::356509773d15a55eecebebe2c66df0db
https://doi.org/10.1212/wnl.0000000000013230
https://doi.org/10.1212/wnl.0000000000013230
Publikováno v:
Int J MS Care
BACKGROUND Multiple sclerosis (MS) typically presents in young adulthood. Recent data show the highest prevalence of MS in people aged 55 to 64 years; however, there are limited studies of this population. METHODS Administrative US claims data from I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e403dc5cfe2a899f88cd416df37a3b30
https://europepmc.org/articles/PMC10010108/
https://europepmc.org/articles/PMC10010108/
Publikováno v:
Drugs-Real World Outcomes
Background Real-world studies of disease-modifying therapies (DMTs) in multiple sclerosis (MS) have reported suboptimal adherence. Objective We aimed to describe treatment patterns, relapses, healthcare resource utilization, and costs in MS patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03bdfc01ed05da100fd3ae74a9dfa641
http://europepmc.org/articles/PMC8605953
http://europepmc.org/articles/PMC8605953
Autor:
Natalia P. Rocha, Odelin Charron, Gabriela D. Colpo, Leigh B. Latham, Jorge E. Patino, Erin Furr Stimming, Leorah Freeman, Antonio L. Teixeira
Publikováno v:
Parkinsonismrelated disorders. 102
The ultimate cause of neuronal death in Huntington's disease (HD) is still uncertain. Apart from impairment in systems handling abnormal proteins, other mechanisms might contribute to neurodegeneration and progression of HD. Decreased cerebral blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8b9696573e774ffb8c32f2a901a339e
https://pubmed.ncbi.nlm.nih.gov/35973322
https://pubmed.ncbi.nlm.nih.gov/35973322
Autor:
Maria Petracca, Mohamed-Mounir El Mendili, Matilde Inglese, Jerry S. Wolinsky, Leorah Freeman, Fred D. Lublin, Amgad Droby, Matteo Moro, Gary Cutter, Monica Margoni, Sirio Cocozza, Stephen Krieger, John Kangarlu
Publikováno v:
European Journal of Neurology
European Journal of Neurology, 2022, 29 (2), pp.515-521. ⟨10.1111/ene.15157⟩
European Journal of Neurology, 2022, 29 (2), pp.515-521. ⟨10.1111/ene.15157⟩
BACKGROUND AND PURPOSE Cerebellar damage is a valuable predictor of disability, particularly in progressive multiple sclerosis. It is not clear if it could be an equally useful predictor of motor disability worsening in the relapsing-remitting phenot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6840477993ca10a026f2360da6f1629
http://hdl.handle.net/11573/1608645
http://hdl.handle.net/11573/1608645
Publikováno v:
Mol Cell Neurosci
Multiple sclerosis (MS) is a neuroinflammatory disorder leading to chronic disability. Brain lesions in MS commonly arise in normal-appearing white matter (NAWM). Genome-wide association studies (GWAS) have identified genetic variants associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47b8035c568018f37f59dea3ba0275ec
https://europepmc.org/articles/PMC8802913/
https://europepmc.org/articles/PMC8802913/
Publikováno v:
Multiple Sclerosis and Related Disorders. 30:69-75
Multiple sclerosis (MS) is a leading cause of disability in adults and requires lifelong treatment. Specialty drugs referred to as disease-modifying therapies (DMTs) have become the standard for multiple sclerosis treatment since the 1990s as they ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0bddf41d8df72d7f373101964a4d4bf
https://doi.org/10.1016/j.msard.2019.02.006
https://doi.org/10.1016/j.msard.2019.02.006